Fulgent Genetics (FLGT) Total Debt Growth (1y) (2021 - 2026)
Fulgent Genetics (FLGT) Total Debt Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | 48.73% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | -20.41% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | -4.01% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | 3.29% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | -72.17% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | -0.07% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | -3.29% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | -0.37% |
| 10 | Fulgent Genetics | 516.41 Mn | 259.38 Mn | 25.68 Mn | -24.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -24.62% |
| Mar 31, 2026 | -24.62% |
| Dec 31, 2025 | -21.46% |
| Sep 30, 2025 | -21.46% |
| Jun 30, 2025 | -21.46% |
| Mar 31, 2025 | -21.46% |
| Dec 31, 2024 | -15.89% |
| Sep 30, 2024 | -0.28% |
| Jun 30, 2024 | -26.68% |
| Mar 31, 2024 | -86.45% |
| Dec 31, 2023 | -83.87% |
| Sep 30, 2023 | -86.70% |
| Jun 30, 2023 | -35.85% |
| Mar 31, 2023 | -10.68% |
| Dec 31, 2022 | 83.71% |
| Sep 30, 2022 | 30.13% |
| Jun 30, 2022 | -64.90% |
| Mar 31, 2022 | 36.89% |
| Dec 31, 2021 | -33.42% |